Leerink Partnrs Analysts Lower Earnings Estimates for CRSP
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Research analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for CRISPR Therapeutics in a research report issued on Tuesday, May 6th. Leerink Partnrs analyst M. Foroohar now expects that the company will post earnings per share of ($1.45) for the quarter, down […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Research analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for CRISPR Therapeutics in a research report issued on Tuesday, May 6th. Leerink Partnrs analyst M. Foroohar now expects that the company will post earnings per share of ($1.45) for the quarter, down […]
